Zinc13732787
Zinc13732787 is an inhibitor of the KCNQ1/KCNE1 potassium channel complex, with no activity against the KCNQ2/KCNQ3 channel. Zinc13732787 reduces axonal growth in human neural stem cells, while exerting no effect on KCNQ1-knockout neural stem cells. Zinc13732787 can be used for research on arrhythmia, epilepsy, and neuropsychiatric disorders.
For research use only. We do not sell to patients.
- CAS No.: 119486-83-8
- Formula: C23H19ClN4O2
- Molecular Weight:418.88
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[1]|
KCNQ1 |
In Vitro
Zinc13732787 (1-100 μM) potently inhibits human KCNQ1/KCNE1 channels in Xenopus laevis oocytes, reducing current amplitude to 47.9% of control at 20 μM, with greater potency against KCNQ1 alone and persistent inhibition after washout[1].
Zinc13732787 (10-100 μM) does not inhibit human KCNQ2/KCNQ3 channels in Xenopus laevis oocytes at concentrations up to 100 μM[1].
Zinc13732787 (1-50 μM; 48 h) reduces neurite outgrowth in human wild-type iPSC-derived NSCs at 1, 5, and 10 μM without affecting proliferation or cytotoxicity, with no effect observed in KCNQ1-knockout NSCs[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
CAS No. 119486-83-8
-
Molecular Weight 418.88
-
Formula C23H19ClN4O2
-
SMILES
O=C1[C@H](NC(NC2=CC=CC(Cl)=C2)=O)N=C(C3=CC=CC=C3)C4=CC=CC=C4N1C
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Gene Editing
Gene editing modify specific sites within the genome through gene deletions, insertions or conversions to study functionally unknown genes or conduct gene therapy. It is also used to change the biological traits of organisms to establish new varieties. Gene editing techniques include zinc finger nuclease (ZFN), transcription activator-like effector nuclease (TALEN), and clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas 9) (CRISPR/Cas9).
-
Cardiac voltage-sensitive optical mapping
Cardiac voltage-sensitive optical mapping records changes in transmembrane potential from cardiac tissue by staining the preparation with a voltage-sensitive dye and imaging fluorescence changes during electrical activation; the resulting optical action potentials can be used to map activation time, action potential duration, conduction velocity, wavefront propagation, and arrhythmia dynamics. The optical signal represents a relative fluorescence change from a tissue volume rather than a single-cell intracellular recording, so spatial resolution, sampling rate, voltage resolution, optical magnification, light penetration, and motion control must be considered together when interpreting optical action potentials.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- Zinc13732787
- 119486-83-8
- Zinc 13732787
- Zinc-13732787
- Potassium Channel
- Xenopus laevis oocytes
- KCNQ2/KCNQ3 channels
- KCNQ1-knockout neuronal stem cells
- cardiac arrhythmias
- human wild-type iPSC-derived NSCs
- neuropsychiatric disorders
- KCNQ1/KCNE1 potassium channel complex
- epilepsy
- human neuronal stem cells
- Inhibitor
- inhibitor
- inhibit